Adoptive Cellular Immunotherapy Market Report – Research, Industry Analysis Reports and Market Demands

Global Adoptive Cellular Immunotherapy Market Size, Status and Forecast 2019-2025

Request for Sample of this report

Buy now

Table of Content

1 Report Overview

1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
- 1.4.1 Global Adoptive Cellular Immunotherapy Market Size Growth Rate by Type (2014-2025)
- 1.4.2 TIL
- 1.4.3 LAK
- 1.4.4 CAR-T
- 1.4.5 TCR-T
- 1.4.6 CIK
- 1.4.7 NK
- 1.4.8 DC
- 1.4.9 Other
1.5 Market by Application
- 1.5.1 Global Adoptive Cellular Immunotherapy Market Share by Application (2014-2025)
- 1.5.2 Hospital
- 1.5.3 Cancer Hospital
- 1.5.4 Centers for Disease Control and Prevention
- 1.5.5 Rehabilitation Center
- 1.5.6 Other
1.6 Study Objectives
1.7 Years Considered

2 Global Growth Trends

2.1 Adoptive Cellular Immunotherapy Market Size
2.2 Adoptive Cellular Immunotherapy Growth Trends by Regions
- 2.2.1 Adoptive Cellular Immunotherapy Market Size by Regions (2014-2025)
- 2.2.2 Adoptive Cellular Immunotherapy Market Share by Regions (2014-2019)
2.3 Industry Trends
- 2.3.1 Market Top Trends
- 2.3.2 Market Drivers
- 2.3.3 Market Challenges
- 2.3.4 Porter’s Five Forces Analysis

3 Market Share by Key Players

3.1 Adoptive Cellular Immunotherapy Market Size by by Players
- 3.1.1 Global Adoptive Cellular Immunotherapy Revenue by by Players (2014-2019)
- 3.1.2 Global Adoptive Cellular Immunotherapy Revenue Market Share by by Players (2014-2019)
- 3.1.3 Global Adoptive Cellular Immunotherapy Market Concentration Ratio (CR5 and HHI)
3.2 Adoptive Cellular Immunotherapy Key Players Head office and Area Served
3.3 Key Players Adoptive Cellular Immunotherapy Product/Solution/Service
3.4 Date of Enter into Adoptive Cellular Immunotherapy Market
3.5 Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type and Application

4.1 Global Adoptive Cellular Immunotherapy Market Size by Type (2014-2019)
4.2 Global Adoptive Cellular Immunotherapy Market Size by Application (2014-2019)

5 United States

5.1 United States Adoptive Cellular Immunotherapy Market Size (2014-2019)
5.2 Adoptive Cellular Immunotherapy Key Players in United States
5.3 United States Adoptive Cellular Immunotherapy Market Size by Type
5.4 United States Adoptive Cellular Immunotherapy Market Size by Application

6 Europe

6.1 Europe Adoptive Cellular Immunotherapy Market Size (2014-2019)
6.2 Adoptive Cellular Immunotherapy Key Players in Europe
6.3 Europe Adoptive Cellular Immunotherapy Market Size by Type
6.4 Europe Adoptive Cellular Immunotherapy Market Size by Application

7 China

7.1 China Adoptive Cellular Immunotherapy Market Size (2014-2019)
7.2 Adoptive Cellular Immunotherapy Key Players in China
7.3 China Adoptive Cellular Immunotherapy Market Size by Type
7.4 China Adoptive Cellular Immunotherapy Market Size by Application

8 Japan

8.1 Japan Adoptive Cellular Immunotherapy Market Size (2014-2019)
8.2 Adoptive Cellular Immunotherapy Key Players in Japan
8.3 Japan Adoptive Cellular Immunotherapy Market Size by Type
8.4 Japan Adoptive Cellular Immunotherapy Market Size by Application

9 Southeast Asia

9.1 Southeast Asia Adoptive Cellular Immunotherapy Market Size (2014-2019)
9.2 Adoptive Cellular Immunotherapy Key Players in Southeast Asia
9.3 Southeast Asia Adoptive Cellular Immunotherapy Market Size by Type
9.4 Southeast Asia Adoptive Cellular Immunotherapy Market Size by Application

10 India

10.1 India Adoptive Cellular Immunotherapy Market Size (2014-2019)
10.2 Adoptive Cellular Immunotherapy Key Players in India
10.3 India Adoptive Cellular Immunotherapy Market Size by Type
10.4 India Adoptive Cellular Immunotherapy Market Size by Application

11 Central & South America

11.1 Central & South America Adoptive Cellular Immunotherapy Market Size (2014-2019)
11.2 Adoptive Cellular Immunotherapy Key Players in Central & South America
11.3 Central & South America Adoptive Cellular Immunotherapy Market Size by Type
11.4 Central & South America Adoptive Cellular Immunotherapy Market Size by Application

12 International Players Profiles

13 Market Forecast 2019-2025

13.1 Market Size Forecast by Regions
13.2 United States
13.3 Europe
13.4 China
13.5 Japan
13.6 Southeast Asia
13.7 India
13.8 Central & South America
13.9 Market Size Forecast by Product (2019-2025)
13.10 Market Size Forecast by Application (2019-2025)

14 Analyst's Viewpoints/Conclusions

15 Appendix

15.1 Research Methodology
- 15.1.1 Methodology/Research Approach
  - 15.1.1.1 Research Programs/Design
  - 15.1.1.2 Market Size Estimation
  - 12.1.1.3 Market Breakdown and Data Triangulation
- 15.1.2 Data Source
  - 15.1.2.1 Secondary Sources
  - 15.1.2.2 Primary Sources
15.2 Disclaimer

Description

Adoptive cellular immunity is the transfer of lymphocytes from the donor to the recipient to enhance its cellular immunity.
In 2018, the global Adoptive Cellular Immunotherapy market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.

This report focuses on the global Adoptive Cellular Immunotherapy status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Adoptive Cellular Immunotherapy development in United States, Europe and China.

The key players covered in this study
Amgen Inc
Autolus Therapeutics Plc
Beijing Immunochina Medical Science & Technology Co Ltd
Bellicum Pharmaceuticals Inc
Bristol-Myers Squibb Co
bluebird bio Inc
CARsgen Therapeutics Ltd
Celgene Corp
Cell Medica Ltd
Cellular Biomedicine Group Inc
Celularity Inc
Celyad SA
Daiichi Sankyo Co Ltd
Fosun Pharmaceutical AG
Gilead Sciences Inc
Guangzhou Anjie Biomedical Technology Co Ltd
Hangzhou Converd Co Ltd
Hebei Senlang Biotechnology Inc Ltd
HRAIN Biotechnology Co Ltd
Juno Therapeutics Inc
Kite Pharma Inc
Nanjing Legend Biotech Co Ltd
NantKwest Inc
Nkarta Inc
Novartis AG
Ono Pharmaceutical Co Ltd
Shanghai Unicar-Therapy Bio-Medicine Technology Co Ltd
Sorrento Therapeutics Inc
Takara Bio Inc

Market segment by Type, the product can be split into
TIL
LAK
CAR-T
TCR-T
CIK
NK
DC
Other

Market segment by Application, split into
Hospital
Cancer Hospital
Centers for Disease Control and Prevention
Rehabilitation Center
Other

Market segment by Regions/Countries, this report covers
United States
Europe
China
Japan
Southeast Asia
India
Central & South America

The study objectives of this report are:
To analyze global Adoptive Cellular Immunotherapy status, future forecast, growth opportunity, key market and key players.
To present the Adoptive Cellular Immunotherapy development in United States, Europe and China.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.

In this study, the years considered to estimate the market size of Adoptive Cellular Immunotherapy are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.